Cite

HARVARD Citation

    Lukey, P. et al. (2019). A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis. European respiratory journal. 53 (3), p. . [Online]. 
  
Back to record